Jupiter Neurosciences(JUNS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

JUNS Jupiter Neurosciences

未开盘 09-03 16:00:00 EDT

3.26

-0.17

-4.96%

盘后3.27

+0.01+0.31%

19:58 EDT

最高3.49	最低3.26	成交量2.06万
今开3.46	昨收3.43	日振幅6.71%
总市值397.92万	流通市值312.39万	总股本122.06万
成交额7.01万	换手率2.15%	流通股本95.82万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"JUNS","market":"US","secType":"STK","nameCN":"Jupiter Neurosciences","latestPrice":3.26,"timestamp":1788465600000,"preClose":3.43,"halted":0,"volume":20612,"hourTrading":{"tag":"盘后","latestPrice":3.27,"preClose":3.26,"latestTime":"19:58 EDT","volume":1947,"amount":6377.42,"timestamp":1788479936254,"change":0.01,"changeRate":0.003067,"amplitude":0.009202},"delay":0,"changeRate":-0.049562682215743545,"floatShares":958239,"shares":1220600,"eps":-18.567553,"marketStatus":"未开盘","change":-0.17,"latestTime":"09-03 16:00:00 EDT","open":3.46,"high":3.49,"low":3.26,"amount":70141.7043376,"amplitude":0.067055,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-18.567553,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1788508800000},"marketStatusCode":0,"adr":0,"listingDate":1733202000000,"exchange":"NASDAQ","adjPreClose":3.43,"preHourTrading":{"tag":"盘前","latestPrice":3.4,"preClose":3.43,"latestTime":"09:28 EDT","volume":362,"amount":1214.3370364,"timestamp":1788442098412,"change":-0.03,"changeRate":-0.008746,"amplitude":0.088921},"postHourTrading":{"tag":"盘后","latestPrice":3.27,"preClose":3.26,"latestTime":"19:58 EDT","volume":1947,"amount":6377.42,"timestamp":1788479936254,"change":0.01,"changeRate":0.003067,"amplitude":0.009202},"volumeRatio":0.147366},"requestUrl":"/m/hq/s/JUNS","defaultTab":"news","newsList":[{"id":"1105390024","title":"Jupiter Neurosciences (纳斯达克: JUNS) 签署最终协议，以最高1亿美元交易价值获得Ala-002美国独家权益","url":"https://stock-news.laohu8.com/highlight/detail?id=1105390024","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1105390024?lang=zh_cn&edition=full","pubTime":"2026-07-21 19:14","pubTimestamp":1784632453,"startTime":"0","endTime":"0","summary":"Jupiter Neurosciences（纳斯达克股票代码：JUNS）已签署一项最终协议，获得在研药物Ala-002在美国的独家商业化权利。此项交易总价值最高可达1亿美元，标志着该公司在拓展其神经科学产品管线方面迈出了关键一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","JUNS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189143379","title":"Pharmala Biotech达成价值高达1亿美元协议，包含333万美元预付款及里程碑付款与特许权使用费","url":"https://stock-news.laohu8.com/highlight/detail?id=1189143379","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1189143379?lang=zh_cn&edition=full","pubTime":"2026-07-21 19:02","pubTimestamp":1784631771,"startTime":"0","endTime":"0","summary":"Pharmala Biotech宣布达成一项潜在总价值高达1亿美元的授权协议。该交易结构包括333万美元的预付款，后续根据研发与商业化里程碑支付的款项，以及基于销售额的特许权使用费。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","JUNS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144839675","title":"Pharmala Biotech签署最终授权协议，授予Jupiter Neurosciences Ala-002在美国的独家权益","url":"https://stock-news.laohu8.com/highlight/detail?id=1144839675","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1144839675?lang=zh_cn&edition=full","pubTime":"2026-07-21 19:01","pubTimestamp":1784631679,"startTime":"0","endTime":"0","summary":"Pharmala Biotech已正式签署一项最终授权协议。根据该协议，Jupiter Neurosciences将获得候选药物Ala-002在美国市场的独家开发与商业化权利。\n此举标志着Jupiter Neurosciences在其神经科学产品管线布局上迈出了关键一步。通过获得Ala-002的独家授权，该公司有望加强其在特定治疗领域的市场地位。协议的财务条款及具体细节未在本次公告中披露。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JUNS","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188736438","title":"SK Pharmteco宣布与孤儿药加速器达成战略合作","url":"https://stock-news.laohu8.com/highlight/detail?id=1188736438","media":"投资观察","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1188736438?lang=zh_cn&edition=full","pubTime":"2026-06-18 21:48","pubTimestamp":1781790533,"startTime":"0","endTime":"0","summary":"SK Inc旗下子公司SK Pharmteco宣布与孤儿药治疗加速器（Orphan Therapeutics Accelerator）建立战略合作关系，双方将共同致力于罕见病疗法的开发与生产。此次合作旨在整合双方在各自领域的专长，加速创新疗法的研发进程，以满足全球罕见病患者的医疗需求。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JUNS","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136782521","title":"Jupiter Neurosciences宣布帕金森病二期a阶段Reset试验患者招募启动","url":"https://stock-news.laohu8.com/highlight/detail?id=1136782521","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1136782521?lang=zh_cn&edition=full","pubTime":"2026-05-27 19:32","pubTimestamp":1779881576,"startTime":"0","endTime":"0","summary":"Jupiter Neurosciences宣布，其针对帕金森病的二期a阶段Reset试验已启动患者招募工作。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","JUNS"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.jupiterneurosciences.com","stockEarnings":[{"period":"1week","weight":-0.3333},{"period":"1month","weight":-0.5804},{"period":"3month","weight":-0.8205},{"period":"6month","weight":-0.8877},{"period":"1year","weight":-0.9649},{"period":"ytd","weight":-0.9574}],"compareEarnings":[{"period":"1week","weight":0.0027},{"period":"1month","weight":0.0024},{"period":"3month","weight":0.0483},{"period":"6month","weight":0.1499},{"period":"1year","weight":0.2011},{"period":"ytd","weight":0.1338}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Jupiter Neurosciences, Inc.于2016年1月在特拉华州注册成立。该公司是一家临床阶段的研究与开发公司，专注于利用其专有的白藜芦醇制剂JOTROL开发针对神经炎症的治疗方法。其主要治疗目标是帕金森病，计划进行IIa期临床试验，并推出了面向消费者的Nugevia产品线，专注于长寿与健康领域。","exchange":"NASDAQ","name":"Jupiter Neurosciences","nameEN":"Jupiter Neurosciences"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Jupiter Neurosciences(JUNS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Jupiter Neurosciences(JUNS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Jupiter Neurosciences,JUNS,Jupiter Neurosciences股票,Jupiter Neurosciences股票老虎,Jupiter Neurosciences股票老虎国际,Jupiter Neurosciences行情,Jupiter Neurosciences股票行情,Jupiter Neurosciences股价,Jupiter Neurosciences股市,Jupiter Neurosciences股票价格,Jupiter Neurosciences股票交易,Jupiter Neurosciences股票购买,Jupiter Neurosciences股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Jupiter Neurosciences(JUNS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Jupiter Neurosciences(JUNS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}